The editor's roundtable: high-density lipoprotein cholesterol. 2007

Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Lipoprotein and Atherosclerosis Research, Cardiovascular Research Institute, Washington Hospital Center, DC, USA. vfriedew@nd.edu

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA
D040242 Risk Reduction Behavior Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives. Risk Reduction,Lifestyle Risk Reduction,Behavior, Risk Reduction,Behaviors, Risk Reduction,Lifestyle Risk Reductions,Risk Reduction Behaviors

Related Publications

Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
January 2018, Journal of clinical lipidology,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
September 2006, Metabolism: clinical and experimental,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
January 1979, The Medical journal of Australia,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
November 2000, The American journal of managed care,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
July 2023, Zhonghua xin xue guan bing za zhi,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
November 2023, Indian heart journal,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
December 2012, Indian journal of endocrinology and metabolism,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
December 1979, Clinical chemistry,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
November 2004, Current cardiology reports,
Vincent E Friedewald, and H Brian Brewer, and Scott M Grundy, and Daniel J Rader, and William C Roberts
January 1989, Arteriosclerosis (Dallas, Tex.),
Copied contents to your clipboard!